Evidence map›Paper›PMID 24765074›Full record

ArticleFrontiers in computational neuroscience2014

Electrostimulation to reduce synaptic scaling driven progression of Alzheimer's disease.

Mark S Rowan, Samuel A Neymotin, William W Lytton

Abstract read
In one paragraph

Article in Frontiers in computational neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Capturing intracellular CaDrug discovery today. Disease models · 2016
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mark S RowanSchool of Computer Science, University of Birmingham Birmingham, UK.
Samuel A NeymotinDepartment Physiology and Pharmacology, State University of New York Downstate Medical Center Brooklyn, NY, USA ; Department Neurobiology, Yale University School of Medicine New Haven, CT, USA.
William W LyttonDepartment Physiology and Pharmacology, State University of New York Downstate Medical Center Brooklyn, NY, USA ; Department Neurology, State University of New York Downstate Medical Center Brooklyn, NY, USA ; Department Neurology, Kings County Hospital Center Brooklyn, NY, USA.

Funding

Extension of NEURON simulator for simulation of reaction-diffusion in neuronsR01MH086638 · NIMH · SUNY DOWNSTATE MEDICAL CENTER · PI LYTTON, WILLIAM W, MCDOUGAL, ROBERT A. · 2010 to 2025
$6.0M
NIMH NIH HHS R01 MH086638
6 · The paper itself

Abstract

Cell death and synapse dysfunction are two likely causes of cognitive decline in AD. As cells die and synapses lose their drive, remaining cells suffer an initial decrease in activity. Neuronal homeostatic synaptic scaling then provides a feedback mechanism to restore activity. This homeostatic mechanism is believed to sense levels of activity-dependent cytosolic calcium within the cell and to adjust neuronal firing activity by increasing the density of AMPA synapses at remaining synapses to achieve balance. The scaling mechanism increases the firing rates of remaining cells in the network to compensate for decreases in network activity. However, this effect can itself become a pathology, as it produces increased imbalance between excitatory and inhibitory circuits, leading to greater susceptibility to further cell loss via calcium-mediated excitotoxicity. Here, we present a mechanistic explanation of how directed brain stimulation might be expected to slow AD progression based on computational simulations in a 470-neuron biomimetic model of a neocortical column. The simulations demonstrate that the addition of low-intensity electrostimulation (neuroprosthesis) to a network undergoing AD-like cell death can raise global activity and break this homeostatic-excitotoxic cascade. The increase in activity within the remaining cells in the column results in lower scaling-driven AMPAR upregulation, reduced imbalances in excitatory and inhibitory circuits, and lower susceptibility to ongoing damage.

Indexed as

Alzheimer's diseasecomputer modelingelectrostimulationhomeostasisinformation transferneocortexneuronal networkssynaptic scaling

Identifiers

PMID24765074
PMCPMC3982056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.